Tuesday, August 25, 2015

Paint it pink

Oh, this is perfect. 
If you happen to be a woman interested in taking Addyi, the first FDA-approved drug intended to treat low libido in women, your doctor will first tell you this: You absolutely cannot drink — at all — as long as you’re taking the drug, because alcohol has been shown to exacerbate its side effects, including fainting, dizziness, and low blood pressure. When the drug hits the market in mid-October, it will come with a black box underlining the importance of abstaining from alcohol while taking the medication.
But here’s the thing. Nobody actually even knows what would happen if a woman taking Addyi were to cheat and have, say, a glass of wine with dinner — because the research on the effects of drinking while on the medication was done almost entirely on men. The alcohol-safety study included 23 men, and a grand total of two women. [my bolding]
Let's take a drug with questionable efficacy (little better than a placebo), and a long list of ill effects, and test its interaction with alcohol, the most worrisome of these effects, on people it is not marketed to. But no worries, because, you know, pink. 

No comments:

Post a Comment